Beta Bionics (BBNX) Share-based Compensation (2023 - 2026)

Beta Bionics has disclosed Share-based Compensation across 4 years of filings, most recently posting $7.0 million for Q2 2026.

• In Q2 2026, Share-based Compensation fell 2.99% year-over-year to $7.0 million; the TTM figure through Jun 2026 stood at $14.8 million (up 105.28% YoY), while the FY2025 annual figure was $25.8 million, up 88.32% from the prior year.
• Share-based Compensation came in at $7.0 million for Q2 2026 at Beta Bionics, up from $7.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $8.2 million in Q1 2025 to a low of $1.4 million in Q1 2024.
• Average Share-based Compensation over 4 years is $4.7 million, with a median of $5.2 million recorded in 2023.
• Year-over-year, Share-based Compensation plunged 70.17% in 2024 and surged 505.49% in 2025.
• Over 4 years, Share-based Compensation stood at $5.2 million in 2023, then sank by 70.17% to $1.6 million in 2024, then surged by 177.26% to $4.3 million in 2025, then surged by 63.05% to $7.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $7.0 million in Q2 2026, $7.0 million in Q1 2026, and $4.3 million in Q4 2025.